Edition:
United Kingdom

Jubilant Life Sciences Ltd (JULS.NS)

JULS.NS on National Stock Exchange of India

680.40INR
17 Oct 2018
Change (% chg)

Rs-12.80 (-1.85%)
Prev Close
Rs693.20
Open
Rs697.10
Day's High
Rs703.70
Day's Low
Rs676.05
Volume
120,536
Avg. Vol
361,337
52-wk High
Rs1,039.00
52-wk Low
Rs586.35

Latest Key Developments (Source: Significant Developments)

Jubilant Life Sciences May Offer Up To 5% Of Share Capital Of JPL To Raise Funds
Friday, 27 Jul 2018 

July 27 (Reuters) - Jubilant Life Sciences Ltd ::JUBILANT LIFE SCIENCES - BOARD APPROVED THAT IF THERE'S OPPORTUNITY IN FUND RAISING BY UNIT, CO MAY OFFER UP TO 5% OF SHARE CAPITAL OF JPL FOR SALE.  Full Article

Jubilant Life Sciences, Jubilant Stock Holding, Others File Appeals Against SEBI Adjudication Order
Wednesday, 25 Apr 2018 

April 25 (Reuters) - Jubilant Life Sciences Ltd ::CO, JUBILANT STOCK HOLDING, OTHERS FILED APPEALS BEFORE SECURITIES APPELLATE TRIBUNAL AGAINST SEBI ADJUDICATION ORDER.  Full Article

India's Jubilant Life Sciences Dec Qtr Consol Profit Up 78 Pct
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Jubilant Life Sciences Ltd ::DEC QUARTER CONSOL NET PROFIT 2.13 BILLION RUPEES VERSUS PROFIT OF 1.19 BILLION RUPEES LAST YEAR.DEC QUARTER TOTAL REVENUE FROM OPERATIONS 20.68 BILLION RUPEES VERSUS 14.92 BILLION RUPEES LAST YEAR.  Full Article

Jubilant Life Sciences Unit Gets sNDA Approval For New Indications From USFDA For Draximage DTPA
Thursday, 28 Dec 2017 

Dec 28 (Reuters) - Jubilant Life Sciences Ltd ::SAYS UNIT GETS SNDA APPROVAL FOR NEW INDICATIONS FROM USFDA FOR DRAXIMAGE® DTPA.  Full Article

Jubilant Life Sciences Says Co Not Got Formal Environmental Nod For Gujarat Pesticide Project
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Jubilant Life Sciences Ltd ::CLARIFIES ON NEWS ITEM ON CO'S PESTICIDE PROJECT IN GUJARAT GETTING GREEN PANEL NOD.SAYS CO HAS NOT GOT ANY FORMAL ENVIRONMENTAL NOD FOR GUJARAT PESTICIDE PROJECT.  Full Article

Jubilant Life Sciences says received ANDA approval for Indomethacin capsules USP
Monday, 28 Aug 2017 

Aug 28 (Reuters) - Jubilant Life Sciences Ltd ::Says Jubilant receives ANDA approval for Indomethacin capsules USP.Says drug is a nonsteroidal anti-inflammatory drug used for treatment of moderate to severe inflammation and reduce pain.  Full Article

Jubilant Life Sciences gets FDA nod for generic version of Crestor drug
Tuesday, 1 Nov 2016 

Jubilant Life Sciences Ltd :Says Jubilant Life Sciences receives ANDA approval for rosuvastatin calcium tablets.  Full Article

BRIEF-Jubilant Life Sciences, Jubilant Stock Holding, Others File Appeals Against SEBI Adjudication Order

* CO, JUBILANT STOCK HOLDING, OTHERS FILED APPEALS BEFORE SECURITIES APPELLATE TRIBUNAL AGAINST SEBI ADJUDICATION ORDER Source text: http://bit.ly/2JkOJp5 Further company coverage: